NAN Navigator and ClinCloud

Navigating Aging Needs, LLC and ClinCloud Clinical Trials have partnered to pilot a virtual support service to improve Alzheimer’s disease trial retention by stabilizing or reducing the burden of family caregiver stress.

View the poster presented at CTAD

Improve Alzheimer’s Disease Trial Retention by Managing Family Caregiver Stress

A diagram showing that the NAN Navigator connects the Family Caregiver Study Partner on the left with the Clinical Trial Site on the right.

 NAN coordinates with the clinical trial site to provide one-on-one virtual support to family caregiver partners through:

Speech bubble with a heart inside

Assessment

Assessment of the patient’s medical, emotional, social, legal/financial risk & caregiver stress.

Checklist with checkmarks on a paper

NAN Plan

Personalized NAN Navigator™ Plan to manage patient risk and caregiver stress.

Icon of a calendar with a blue background

Follow-up

Weekly meetings via Zoom to implement NAN Plan and monitor caregiver stress.

Blue circular icon with a lowercase 'i' in black at the center, representing information.

Resources

Access to NAN website for high-quality caregiving resources.

 Examples of how NAN reduces family caregiver stress of trial participation:

Icon of a suitcase with travel stickers and a handle

Travel

A family caregiver study partner worried the clinical trials schedule would interfere with a long-planned trip.

NAN and the clinical trials team collaborated to successfully adjust the schedule.

Thermometer icon inside a warning triangle

Medication Storage

A family caregiver study partner was at risk of compromising the investigational product because they did not have a way to keep it at the required temperature while traveling.

NAN and the clinical trials team collaborated to identify a storage solution. They enjoyed their trip and completed all study activities.

Social media comment bubble with a thumbs-up icon

Communication

A family caregiver study
partner was frustrated by communication difficulties between the patient and the clinical trials team.

NAN provided recommendations to improve communication with the Alzheimer’s patient.